(Q56804777)

English

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis (English)

0 references

multiple sclerosis

0 references

0 references

1 reference

based on heuristic

inferred from title

Massimo Filippi

object named as

Massimo Filippi

2

0 references

1

object named as

Giancarlo Comi

0 references

Jerry S Wolinsky

3

object named as

Jerry S. Wolinsky

0 references

publication date

2001

0 references

Annals of Neurology

0 references

49

0 references

3

0 references

290-297

0 references

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2FANA.64

21 January 2018

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2FANA.64

21 January 2018

Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment

1 reference

https://api.crossref.org/works/10.1002%2FANA.64

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1002%2FANA.64

21 January 2018

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FANA.64

21 January 2018

Identifiers

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56804777&oldid=1778962735"